16-fluoroestradiol has been researched along with fulvestrant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellis, GK; Gralow, JR; Krohn, KA; Kurland, BF; Lawton, TJ; Linden, HM; Link, JM; Livingston, RB; Mankoff, DA; Peterson, LM; Petra, PH; Schubert, EK; Specht, JM | 1 |
| Carlson, KE; Chan, SR; Dence, CS; Fettig, NM; Fowler, AM; Jeyakumar, M; Katzenellenbogen, JA; Schreiber, RD; Sharp, TL; Welch, MJ; Zhou, D | 1 |
| Bénard, F; Langlois, R; Lecomte, R; Ouellet, R; Paquette, M; Phoenix, S; Turcotte, EE; van Lier, JE | 1 |
3 other study(ies) available for 16-fluoroestradiol and fulvestrant
| Article | Year |
|---|---|
Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Fulvestrant; Humans; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Retrospective Studies; Selective Estrogen Receptor Modulators; Tamoxifen; Uterus | 2011 |
Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Hormonal; Blotting, Western; Cell Line, Tumor; Estradiol; Estrogen Receptor alpha; Female; Fluorodeoxyglucose F18; Fulvestrant; Mammary Neoplasms, Experimental; Mice; Mice, Knockout; Neoplasm Transplantation; Norpregnenes; Positron-Emission Tomography; Predictive Value of Tests; Rabbits; Radiopharmaceuticals; Receptors, Steroid; STAT1 Transcription Factor | 2012 |
Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model.
Topics: Animals; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Estradiol; Female; Fulvestrant; Humans; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Receptors, Estrogen; Tissue Distribution | 2013 |